Back to Search
CHRISTOPHER WEYER, D.O.
D.O.
MOHS-Micrographic Surgery Physician
NPI: 1851515381IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology Physician
Dermatology
Code: 207N00000X
2007030797(MO)
MOHS-Micrographic Surgery PhysicianPrimary
Dermatology — MOHS-Micrographic Surgery
Code: 207ND0101X
006021(AZ)34.009917(OH)
CMS Specialties
PrimaryDERMATOLOGY
Education
AT STILL UNIVERSITY OF HEALTH SCIENCES, COLLEGE OF OSTEO MED, KIRKSVILLE
Class of 2006
Research & Publications (20)
Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians.
PMID 11882337·Atherosclerosis·2002
8-other
Exaggerated pancreatic polypeptide secretion in Pima Indians: can an increased parasympathetic drive to the pancreas contribute to hyperinsulinemia, obesity, and diabetes in humans?
PMID 11229433·Metabolism·2001
8-other
Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.
PMID 11151758·Diabetologia·2000
8-other
Energy metabolism after 2 y of energy restriction: the biosphere 2 experiment.
PMID 11010936·Am J Clin Nutr·2000
8-other
Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats.
PMID 19543217·Obesity (Silver Spring)·2010
7-preclinical
Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy.
PMID 19521351·Obesity (Silver Spring)·2009
4-observational
Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity.
PMID 18753666·Diabetes Care·2008
2-rct
Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals.
PMID 18258617·Am J Clin Nutr·2008
8-other
Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies.
PMID 18458326·Proc Natl Acad Sci U S A·2008
7-preclinical
Role of islet-, gut-, and adipocyte-derived hormones in the central control of food intake and body weight: implications for an integrated neurohormonal approach to obesity pharmacotherapy.
PMID 18473755·Curr Diabetes Rev·2008
6-review
Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.
PMID 18669592·Endocrinology·2008
4-observational
Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
PMID 18560368·Int J Obes (Lond)·2008
7-preclinical
Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study.
PMID 17504894·J Clin Endocrinol Metab·2007
3-trial
Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study.
PMID 17505051·Am J Physiol Endocrinol Metab·2007
4-observational
Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects.
PMID 17495194·Obesity (Silver Spring)·2007
2-rct
Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
PMID 17761760·Endocrinology·2007
7-preclinical
Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes.
PMID 15843914·Diabetologia·2005
3-trial
Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets.
PMID 15891954·Exp Clin Endocrinol Diabetes·2005
3-trial
The effect of pramlintide on hormonal, metabolic or symptomatic responses to insulin-induced hypoglycaemia in patients with type 1 diabetes.
PMID 16050943·Diabetes Obes Metab·2005
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 150 S CORONADO DR STE 110
SIERRA VISTA, AZ 85635 - Phone
- (520) 458-1787
Quick Facts
- NPI
- 1851515381
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 20
- Publications
- 20
Are you this provider?
Claim Your Profile